PACS Group, Inc.
NYSE:PACSFinancial - Conglomerates
+$0.41 today
- Market cap
- $7.35B
- Beta
- 0.00
- P/E (TTM)
- 23.0
- EPS (TTM)
- $1.55
Volume 0.78M
Average 0.84M
PACS EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
PACS Group, Inc.NYSE: PACS
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA grows, but more slowly than its trailing trend
Q2 FY2026 EBITDA of $132M rose 37.3% year over year, behind the +62.7% change in trailing-twelve-month EBITDA. Sequentially, it fell 4.4% from the prior quarter. Over 3 fiscal years it compounded at +12.8% a year.
Context
- EBITDA amounted to 6.9% of revenue in FY2025, up 2.3 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 4 analysts of $728.75M (+99.3%) for the fiscal year ending Dec 2026, a step up from the +95.8% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $132M-4.4% QoQ
- Last fiscal yearDec 2025
- $365.57M+95.8% YoY
- LTMJun 2026
- $480.11M+62.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +37.3% | +72.3% | +35.0 pp |
| 1 year | +95.8% | +99.3% | +3.5 pp |
| 3-year CAGR | +12.8% | +41.7% | +28.9 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 365.57M USD
- Year-over-year change
- +95.8%
- 4-year CAGR
- +40.5%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 365.57M | +95.8% |
| FY2024 | 2024-12-31 | 186.7M | -19.8% |
| FY2023 | 2023-12-31 | 232.87M | -8.6% |
| FY2022 | 2022-12-31 | 254.89M | +171.6% |
| FY2021 | 2021-12-31 | 93.86M | — |
EBITDA vs competitors
How PACS compares with its peers on the latest reported figures
- PACS's LTM Jun 2026 EBITDA of $480.11M is the 5th highest of the 11 companies compared; the peer median is $351.74M.
- Its year-over-year change of +62.7% is the 4th highest of 11, against a peer median of +20.4%.
- EBITDA amounts to 8.6% of revenue for PACS, versus a peer median of 13.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $15.84B | +10.3% | +5.5% | 20.3% | |
| LTM Mar 2026 | $4.96B | +296.6% | +20.0% | 23.1% | |
| LTM Jun 2026 | $1.5B | +14.8% | +17.3% | 24.2% | |
| LTM Jun 2026 | $621.28M | +18.2% | +16.4% | 11.3% | |
| LTM Jun 2026 | $480.11M | +62.7% | +12.8% | 8.6% | |
| LTM Sep 2026 | $411.59M | -8.8% | +3.9% | 14.0% | |
| LTM Mar 2026 | $291.89M | +36.3% | — | 33.2% | |
| LTM Sep 2026 | $207.86M | +10.1% | +46.3% | 13.1% | |
| LTM Jun 2026 | $131.66M | +132.4% | — | 8.3% | |
| LTM Mar 2026 | $60.01M | +22.5% | +51.2% | 5.9% | |
| LTM Mar 2026 | $4.36M | +191.5% | -28.5% | 0.5% | |
| Peer median (excluding PACS) | $351.74M | +20.4% | +16.8% | 13.5% | |
Competitors are the stored peer set for PACS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.17B | 2.42B | 3.11B | 4.09B | 5.29B |
| Cost of Revenue | 979.22M | 2.02B | 2.66B | 3.3B | 4.13B |
| Gross Profit | 187.35M | 400.68M | 447.07M | 792.64M | 1.16B |
| Gross Margin | 16.1% | 16.5% | 14.4% | 19.4% | 21.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 96.83M | 149.01M | 213.66M | 343.81M | 415.07M |
| Operating Expenses | 103.99M | 171.32M | 239.3M | 669.57M | 849.64M |
| Depreciation & Amortization | 7.15M | 22.31M | 25.63M | 40.81M | 55.66M |
| EBITDA | 93.86M | 254.89M | 232.87M | 186.7M | 365.57M |
| EBITDA Margin | 8.0% | 10.5% | 7.5% | 4.6% | 6.9% |
| Operating Income | 83.36M | 229.36M | 207.77M | 123.07M | 309.6M |
| Operating Margin | 7.1% | 9.5% | 6.7% | 3.0% | 5.9% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 5.28M | 25.54M | 49.92M | 44.34M | 28.36M |
| Other Income / Expenses | (1.93M) | (22.32M) | (50.46M) | (21.52M) | (25.15M) |
| Income Before Tax | 81.43M | 207.05M | 157.32M | 101.55M | 284.45M |
| Pre-Tax Margin | 7.0% | 8.5% | 5.1% | 2.5% | 5.4% |
| Income Tax Expense | 33.48M | 56.55M | 44.44M | 46.21M | 92.99M |
| Net Income | 47.95M | 150.5M | 112.87M | 55.76M | 191.54M |
| Net Margin | 4.1% | 6.2% | 3.6% | 1.4% | 3.6% |
| EPS (Basic) | 0.32 | 1.00 | 0.75 | 0.38 | 1.23 |
| EPS (Diluted) | 0.32 | 1.00 | 0.75 | 0.38 | 1.22 |
| Weighted Avg Shares | 150.15M | 150.15M | 150.15M | 146.66M | 156.18M |
| Weighted Avg Shares (Diluted) | 150.15M | 150.15M | 150.15M | 148.57M | 156.7M |
PACS Group, Inc.
NYSE:PACS
Intrinsic Alpha fair value
Locked
Current Price
$46.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.